Platinum Priority – Prostate CancerEditorial by Benjamin L. Maughan and Mario A. Eisenberger on pp. 732–733 of this issueProstate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer
Editorial by Benjamin L. Maughan and Mario A. Eisenberger on pp. 732–733 of this issue
Under a Creative Commons license
open access
Keywords
Abiraterone acetate
Metastatic castration-resistant prostate cancer
Prostate-specific antigen
Cited by (0)
© 2016 European Association of Urology. Published by Elsevier B.V.